| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 09/14/2006 | US20060205017 Microorganism genomics, compositions and methods related thereto |
| 09/14/2006 | US20060205016 Protein a based binding domains with desirable activities |
| 09/14/2006 | US20060205015 Method for detecting the interactions between a G protein-coupled receptor (GPCR) and one of the Galpha or Gbetagamma subunits |
| 09/14/2006 | US20060205011 Combinatorial artificial receptors including tether building blocks on scaffolds |
| 09/14/2006 | US20060204998 Alleles of the human mu opioid receptor, diagnostic methods using said alleles, and methods of treatment based thereon |
| 09/14/2006 | US20060204986 Ligand bound viral envelope protein for use in inducing anti-human immunodeficiency virus antibodies; treatment and prevention of viral disease |
| 09/14/2006 | US20060204982 Novel compositions and methods for cancer |
| 09/14/2006 | US20060204967 Methods for identifying risk of breast cancer and treatments thereof |
| 09/14/2006 | US20060204966 selecting therapy for a human subject having a solid epithelial tumor that overexpresses ErbB2 comprising determining whether the tumor expresses p95ErbB2; reversible dual tyrosine kinase inhibitor of both ErbB2 and epidermal growth factor receptor |
| 09/14/2006 | US20060204962 Genetic polymorphisms as predictive diagnostics for adverse drug reactions (adr) and drug efficacy |
| 09/14/2006 | US20060204958 Methods for diagnosing htlv-i-mediated diseases |
| 09/14/2006 | US20060204957 Mta1s, a steriod hormone receptor corepressor |
| 09/14/2006 | US20060204955 Method for the production of bacterial toxins |
| 09/14/2006 | US20060204954 Compositions and methods for binding agglomeration proteins |
| 09/14/2006 | US20060204529 Crosslinked elastin and process for producing the same |
| 09/14/2006 | US20060204524 Genetically engineered clostridial genes, proteins encoded by the engineered genes, and uses thereof |
| 09/14/2006 | US20060204521 Vector carrying a polynucleotide which encodes a polypeptide having the ability to stimulate an immune response against the polypeptide of Seq ID No:24 |
| 09/14/2006 | US20060204520 Vaccine composition |
| 09/14/2006 | US20060204519 Genetic vaccine for generating immunity to human immunodeficiency virus-1 |
| 09/14/2006 | US20060204516 Compositions and methods for enhancing the immunogenicity of antigens |
| 09/14/2006 | US20060204515 Cholesterol-containing compounds and their use as immunogens against borrelia burgdorferi |
| 09/14/2006 | US20060204513 Novel surface protein (hbsag) variant of the hepatitis b virus |
| 09/14/2006 | US20060204512 Ephrin extracellular domain polypeptides for use in diagnosis prevention and treatment of cell proliferative disorders |
| 09/14/2006 | US20060204510 Bv8 nucleic acids and polypeptides with mitogenic activity |
| 09/14/2006 | US20060204508 Treatment of autoimmune diseases using an activator for the notch signalling pathway |
| 09/14/2006 | US20060204507 Method for generating an immune response and reagents therefor |
| 09/14/2006 | US20060204501 Drug for cancer therapy |
| 09/14/2006 | US20060204498 Novel antagonists of cxcr3-binding cxc chemokines |
| 09/14/2006 | US20060204494 Methionine sulfoxide antibodies |
| 09/14/2006 | US20060204483 determining whether a target cell expresses telomerase reverse transcriptase (TRT) by combining human T lymphocytes ex vivo with antigen-presenting cells containing a polypeptide that comprises at least 8 consecutive amino acids of telomerase reverse transcriptase |
| 09/14/2006 | US20060204479 Adeno-associated virus serotype 1 nucleic acid sequences, vectors and host cells containing same |
| 09/14/2006 | US20060204477 Helper virus-free herpesvirus amplicon particles and uses thereof |
| 09/14/2006 | US20060204473 Synthetic hyperglycosylated, and hyperglycosylated protease-resistant polypeptide variants, oral formulations and methods of using the same |
| 09/14/2006 | US20060204454 Method for improving the functional properties of a globular protein, protein thus prepared, use thereof and products containing the protein |
| 09/14/2006 | CA2608070A1 Chimeric proteins with phosphatidylserine binding domains |
| 09/14/2006 | CA2602127A1 Human leptin-derived polypeptides and uses thereof |
| 09/14/2006 | CA2601133A1 Modified pyy (3-36) peptides and their effects on feeding behaviour |
| 09/14/2006 | CA2601029A1 Photoproteins with enhanced bioluminescence and their use as intracellular calcium indicators |
| 09/14/2006 | CA2600951A1 Growth factor mutants with improved biological activity |
| 09/14/2006 | CA2600907A1 Coagulation and fibrinolytic cascades modulator |
| 09/14/2006 | CA2600905A1 Varicella zoster virus vaccine |
| 09/14/2006 | CA2600749A1 Dimeric or multimeric microproteins |
| 09/14/2006 | CA2600460A1 High pressure processing of metal ion lactoferrin |
| 09/14/2006 | CA2600370A1 Bioactive fus1 peptides and nanoparticle-polypeptide complexes |
| 09/14/2006 | CA2599792A1 Screening method, process for purifying of non-diffusible a-beta oligomers, selective antibodies against said non-diffusible a-beta oligomers and a process for manufacturing of said antibodies |
| 09/14/2006 | CA2599723A1 Modified transferrin fusion proteins |
| 09/14/2006 | CA2599540A1 Lipocalin protein |
| 09/14/2006 | CA2597485A1 Methods and compositions for modulating tweak and fn14 activity |
| 09/13/2006 | EP1700920A1 Synthetic antibiotics |
| 09/13/2006 | EP1700918A2 Activatable recombinant neurotoxins |
| 09/13/2006 | EP1700916A1 Novel centromeric protein shugoshin |
| 09/13/2006 | EP1700913A1 Fluorescent proteins |
| 09/13/2006 | EP1700911A1 In vitro method for disassembly/reassembly of papillomavirus virus-like particles (VLPs) |
| 09/13/2006 | EP1700868A2 A method for removing an antibody from blood or plasma |
| 09/13/2006 | EP1700867A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/13/2006 | EP1700866A2 Cerebral organic anion transporter and its gene |
| 09/13/2006 | EP1700865A1 Photoproteins with enhanced bioluminescence and their use as intracellular calcium indicators |
| 09/13/2006 | EP1700864A1 Method for the production of S-adenosylmethionine by fermentation |
| 09/13/2006 | EP1700096A2 Detection of conformationally altered proteins and prions |
| 09/13/2006 | EP1699931A2 Maize metallothionein 2 promoter and methods of use |
| 09/13/2006 | EP1699926A2 Stress tolerant plants and methods thereof |
| 09/13/2006 | EP1699925A1 Il-23 and its receptor; related reagents and methods |
| 09/13/2006 | EP1699920A2 Novel recombinant proteins with n-terminal free thiol |
| 09/13/2006 | EP1699919A1 A respiratory syncytial virus with a genomic deficiency complemented in trans |
| 09/13/2006 | EP1699914A2 Novel sodium channel |
| 09/13/2006 | EP1699824A2 Ztnf 12, a tumor necrosis factor |
| 09/13/2006 | EP1699823A2 Use of il-18 binding protein in inflammations |
| 09/13/2006 | EP1699822A2 Il-7 fusion proteins with antibody portions, their preparation and their use |
| 09/13/2006 | EP1699821A1 Fc-ERYTHROPOIETIN FUSION PROTEIN WITH IMPROVED PHARMACOKINETICS |
| 09/13/2006 | EP1699820A2 Neutralizing epitope-based growth enhancing vaccine |
| 09/13/2006 | EP1699819A2 Treatment of coronary or peripheral ischemia |
| 09/13/2006 | EP1699818A2 Angiogenesis affecting polypeptides, proteins, and compositions, and methods of use |
| 09/13/2006 | EP1699817A1 Avidin mutants |
| 09/13/2006 | EP1699816A2 Genes encoding proteins with pesticidal activity |
| 09/13/2006 | EP1699813A2 Isozyme-specific antagonists of protein kinase c |
| 09/13/2006 | EP1699811A1 A process for the preparation and purification of recombinant proteins |
| 09/13/2006 | EP1699492A2 Targeted immunogens |
| 09/13/2006 | EP1699481A2 Methods and compositions comprising bacteriophage nanoparticles |
| 09/13/2006 | EP1699479A1 Synthetic protein as tumor-specific vaccine |
| 09/13/2006 | EP1699478A2 Treating inflammation using a biological agent that causes cells to release cytokine receptors |
| 09/13/2006 | EP1699469A2 Recombinant factor viii having increased specific activity |
| 09/13/2006 | EP1699460A2 Use of enzymatic inhibitors of h-prune for the prevention and treatment of the metastases of tumours overexpressing h-prune |
| 09/13/2006 | EP1699420A1 Membranes incorporating recognition moieties |
| 09/13/2006 | EP1623018A4 Mptens as modifiers of the pten/igf pathway and methods of use |
| 09/13/2006 | EP1620555A4 Rhesus monkey bombesin receptor subtype-3 (brs-3), nucleotides encoding same, and uses thereof |
| 09/13/2006 | EP1499180A4 Cancer models |
| 09/13/2006 | EP1366074B1 Modified granulocyte macrophage colony stimulating factor (gm-csf) with reduced immunogenicity |
| 09/13/2006 | EP1364020B1 Position dependent recognition of gnn nucleotide triplets by zinc fingers |
| 09/13/2006 | EP1363944B1 High-affinity antagonists of elr-cxc chemokines |
| 09/13/2006 | EP1355655B1 Compositions and methods for improving kidney function |
| 09/13/2006 | EP1341813B1 Use of l-carnitine as stabilizing agent of proteins |
| 09/13/2006 | EP1339840B1 Schizophrenia-related voltage-gated ion channel gene and protein |
| 09/13/2006 | EP1312677B1 Nucleic acids encoding lettuce big-vein virus proteins and utilization thereof |
| 09/13/2006 | EP1311693B1 Transcription factor stress-related protein and methods of use in plants |
| 09/13/2006 | EP1306434B1 Genes encoding proteins capable of regenerating luciferin, recombinant dna and process for producing protein capable of regenerating luciferin |
| 09/13/2006 | EP1305406B1 Modulation of gamma-secretase activity |
| 09/13/2006 | EP1302477B1 Peptide fructose and complex thereof with binding protein |
| 09/13/2006 | EP1282643B1 Anti-inflammatory compounds and uses thereof |
| 09/13/2006 | EP1280828B1 Anthrax-specific antigen, vaccines comprising said antigen, anthrax-specific antibodies, and their uses |
| 09/13/2006 | EP1224288B1 Processed human chemokine phc-1 |